Vigil Neuroscience, Inc. clinical trials
Acquired by Sanofi, Aug 6, 2025 · source ↗
The registry lists 3 studies whose lead sponsor is Vigil Neuroscience, Inc.. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Aug 13, 2025.
- 3studies on the registry
- 0open to participants now
Before and after it joined Sanofi
- First submitted before Vigil Neuroscience, Inc. became part of Sanofi
- 3
- First submitted after Vigil Neuroscience, Inc. became part of Sanofi
- 0
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
All 3 at a glance
Where each study is in its life, its phase and its countries. Each count opens them in search.
Over the years
- 121
- 22
- 23
- 24
- 25
- 026
By the year each study started. 2026 so far in the lighter column.
Registry sponsor names on this page
- Vigil Neuroscience, Inc.3 studies
Something wrong with this grouping? Tell us on the Sanofi page.
Studies
Recruiting first, then most recently updated. Showing 3 of 3. All Sanofi studies →
- Natural History Study in Adult-Onset Leukoencephalopathy With Axonal Spheroids and Pigmented GliaTerminatedNCT05020743
Sponsor listed in the registry: Vigil Neuroscience, Inc. · First submitted before Vigil Neuroscience, Inc. became part of Sanofi
- A Study of VGL101 in Patients With Adult-Onset Leukoencephalopathy With Axonal Spheroids and Pigmented GliaTerminatedNCT05677659Phase 2
Sponsor listed in the registry: Vigil Neuroscience, Inc. · First submitted before Vigil Neuroscience, Inc. became part of Sanofi
- A Phase 1 Study of VG-3927 in Healthy Adults and Patients With Alzheimer's DiseaseCompletedNCT06343636Phase 1
Sponsor listed in the registry: Vigil Neuroscience, Inc. · First submitted before Vigil Neuroscience, Inc. became part of Sanofi